MreB Inhibitor A22, Disrupts bacterial actin cytoskeleton, 10mg, CAS# 22816-60-0

MreB Inhibitor A22, Disrupts bacterial actin cytoskeleton, 10mg, CAS# 22816-60-0

ML401, EBI2 (GPR183) antagonist, 5mg, CAS# 1597489-14-9

ML401, EBI2 (GPR183) antagonist, 5mg, CAS# 1597489-14-9

MreB_Inhibitor_A22, Disrupts bacterial actin cytoskeleton, 50mg, CAS# 22816-60-0

$175.00
2-(3,4-Dichloro-benzyl)-isothiourea Purity: hydrochloride Purity: >98% by HPLC NMR (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-5275-50mg-EA
MreB_Inhibitor_A22, Disrupts bacterial actin cytoskeleton, 50mg, CAS# 22816-60-0 is available to buy in increments of 1

Product Details

Download Details and Specifications

A22 disrupts the actin cytoskeleton of bacteria causing defects in morphology and chromosome segregation.1 It is a competitive inhibitor of ATP binding to MreB and has the ability to disassemble the actin cytoskeleton in bacterial cells.1 It displays antibacterial activity against P. aeruginosa (among many others) including multidrug-resistant clinical isolates and points to MreB as a new target for antibacterial development.2 A22 significantly disrupts biofilm formation by interfering with the ability of bacterial cells to maintain shape and adherence to surfaces.3

CAS Number: 22816-60-0

Manufacturer Part Number/SKU: 10-5275-50mg-EA

Tags: Focus Biomolecules